Literature DB >> 33168762

Recurrent thunderclap headaches from reversible cerebral vasoconstriction syndrome associated with duloxetine, xylometazoline and rhinitis medicamentosa.

Hoang Pham1, Stéphanie Gosselin-Lefebvre2, Persia Pourshahnazari2, Samuel Yip2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33168762      PMCID: PMC7669296          DOI: 10.1503/cmaj.201234

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  10 in total

Review 1.  Spontaneous subarachnoid haemorrhage.

Authors:  R Loch Macdonald; Tom A Schweizer
Journal:  Lancet       Date:  2016-09-13       Impact factor: 79.321

2.  Primary angiitis of the CNS and reversible cerebral vasoconstriction syndrome: A comparative study.

Authors:  Hubert de Boysson; Jean-Jacques Parienti; Jérôme Mawet; Caroline Arquizan; Grégoire Boulouis; Cécilia Burcin; Olivier Naggara; Mathieu Zuber; Emmanuel Touzé; Achille Aouba; Marie-Germaine Bousser; Christian Pagnoux; Anne Ducros
Journal:  Neurology       Date:  2018-09-19       Impact factor: 9.910

Review 3.  Subarachnoid Hemorrhage.

Authors:  Michael T Lawton; G Edward Vates
Journal:  N Engl J Med       Date:  2017-07-20       Impact factor: 91.245

4.  RCVS2 score and diagnostic approach for reversible cerebral vasoconstriction syndrome.

Authors:  Eva A Rocha; M Akif Topcuoglu; Gisele S Silva; Aneesh B Singhal
Journal:  Neurology       Date:  2019-01-11       Impact factor: 9.910

Review 5.  Canadian Stroke Best Practice Recommendations for Acute Stroke Management: Prehospital, Emergency Department, and Acute Inpatient Stroke Care, 6th Edition, Update 2018.

Authors:  J M Boulanger; M P Lindsay; G Gubitz; E E Smith; G Stotts; N Foley; S Bhogal; K Boyle; L Braun; T Goddard; Mks Heran; N Kanya-Forster; E Lang; P Lavoie; M McClelland; C O'Kelly; P Pageau; J Pettersen; H Purvis; M Shamy; D Tampieri; B vanAdel; R Verbeek; D Blacquiere; L Casaubon; D Ferguson; Y Hegedus; G J Jacquin; M Kelly; N Kamal; B Linkewich; C Lum; B Mann; G Milot; N Newcommon; P Poirier; W Simpkin; E Snieder; A Trivedi; R Whelan; M Eustace; E Smitko; K Butcher
Journal:  Int J Stroke       Date:  2018-07-18       Impact factor: 5.266

6.  Atraumatic convexal subarachnoid hemorrhage: clinical presentation, imaging patterns, and etiologies.

Authors:  S Kumar; R P Goddeau; M H Selim; A Thomas; G Schlaug; A Alhazzani; D E Searls; L R Caplan
Journal:  Neurology       Date:  2010-03-16       Impact factor: 9.910

7.  Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association.

Authors:  E Sander Connolly; Alejandro A Rabinstein; J Ricardo Carhuapoma; Colin P Derdeyn; Jacques Dion; Randall T Higashida; Brian L Hoh; Catherine J Kirkness; Andrew M Naidech; Christopher S Ogilvy; Aman B Patel; B Gregory Thompson; Paul Vespa
Journal:  Stroke       Date:  2012-05-03       Impact factor: 7.914

Review 8.  Reversible Cerebral Vasoconstriction Syndrome: Recognition and Treatment.

Authors:  Cecilia Cappelen-Smith; Zeljka Calic; Dennis Cordato
Journal:  Curr Treat Options Neurol       Date:  2017-06       Impact factor: 3.598

9.  The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients.

Authors:  Anne Ducros; Monique Boukobza; Raphaël Porcher; Mariana Sarov; Dominique Valade; Marie-Germaine Bousser
Journal:  Brain       Date:  2007-11-19       Impact factor: 13.501

10.  Thunderclap headache and reversible segmental cerebral vasoconstriction associated with use of oxymetazoline nasal spray.

Authors:  Andrea H S Loewen; Mark E Hudon; Michael D Hill
Journal:  CMAJ       Date:  2004-09-14       Impact factor: 8.262

  10 in total
  1 in total

1.  The selectivity of α-adrenoceptor agonists for the human α1A, α1B, and α1D-adrenoceptors.

Authors:  Richard G W Proudman; Jillian G Baker
Journal:  Pharmacol Res Perspect       Date:  2021-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.